ES2138070T3 - Proceso para la preparacion de formas farmaceuticas de liberacion controlada y las formas obtenidas de esta manera. - Google Patents

Proceso para la preparacion de formas farmaceuticas de liberacion controlada y las formas obtenidas de esta manera.

Info

Publication number
ES2138070T3
ES2138070T3 ES94906994T ES94906994T ES2138070T3 ES 2138070 T3 ES2138070 T3 ES 2138070T3 ES 94906994 T ES94906994 T ES 94906994T ES 94906994 T ES94906994 T ES 94906994T ES 2138070 T3 ES2138070 T3 ES 2138070T3
Authority
ES
Spain
Prior art keywords
pct
forms
excipients
sec
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94906994T
Other languages
English (en)
Inventor
Giuseppe Motta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saitec SRL
Original Assignee
Saitec SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT92BO455 external-priority patent/IT1260242B/it
Priority claimed from ITBO930294A external-priority patent/IT1263445B/it
Priority claimed from IT93BO000460A external-priority patent/IT1268454B1/it
Application filed by Saitec SRL filed Critical Saitec SRL
Application granted granted Critical
Publication of ES2138070T3 publication Critical patent/ES2138070T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTA UN PROCESO MEJORADO PARA PREPARAR FORMAS FARMACEUTICAS DE LIBERACION CONTROLADA QUE COMPRENDE LA EXPOSICION DE UNA MEZCLA QUE COMPRENDE UNO O MAS EXCIPIENTES Y UNO O MAS INGREDIENTES ACTIVOS COMPATIBLES ENTRE SI Y CON DICHOS EXCIPIENTES A ACCIONES MECANICAS O ELECTROMECANICAS DURANTE UN PERIODO DE TIEMPO BIEN ESTABLECIDO Y DENTRO DE UNA AMPLIA GAMA DE FRECUENCIAS PARA DAR COMO RESULTADO TABLETAS, MATRICES O PELICULAS MONO O MULTIESTRATIFICADAS. DICHAS FORMAS PUEDEN ROMPERSE OPCIONALMENTE PARA DAR COMO RESULTADO UN GRANULADO O UN POLVO. DEPENDIENDO DEL EXCIPIENTE EMPLEADO, PUEDE OBTENERSE UNA LIBERACION RETARDADA O RAPIDA, PERO SIEMPRE CONTROLADA, DEL INGREDIENTE ACTIVO.
ES94906994T 1992-12-23 1993-12-23 Proceso para la preparacion de formas farmaceuticas de liberacion controlada y las formas obtenidas de esta manera. Expired - Lifetime ES2138070T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT92BO455 IT1260242B (it) 1992-12-23 1992-12-23 Procedimento per preparare forme farmaceutiche a rilascio controllato ritardato del principio attivo e le forme farmaceutiche cosi' ottenute.
ITBO930294A IT1263445B (it) 1993-06-24 1993-06-24 Procedimento per preparare forme farmaceutiche a rilascio controllato/ritardato del principio attivo e le forme farmaceutiche cosi' ottenute
IT93BO000460A IT1268454B1 (it) 1993-11-12 1993-11-12 Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.
PCT/IT1993/000136 WO1994014421A2 (en) 1992-12-23 1993-12-23 Process for preparing controlled release pharmaceutical forms and the forms thus obtained

Publications (1)

Publication Number Publication Date
ES2138070T3 true ES2138070T3 (es) 2000-01-01

Family

ID=27273889

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94906994T Expired - Lifetime ES2138070T3 (es) 1992-12-23 1993-12-23 Proceso para la preparacion de formas farmaceuticas de liberacion controlada y las formas obtenidas de esta manera.

Country Status (14)

Country Link
US (1) US5662935A (es)
EP (1) EP0675710B1 (es)
JP (1) JP3459421B2 (es)
KR (1) KR100297541B1 (es)
AT (1) ATE183641T1 (es)
AU (1) AU683044B2 (es)
BR (1) BR9307736A (es)
CA (1) CA2151396C (es)
DE (1) DE69326163T2 (es)
DK (1) DK0675710T3 (es)
ES (1) ES2138070T3 (es)
GR (1) GR3031936T3 (es)
RU (1) RU2128499C1 (es)
WO (1) WO1994014421A2 (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
IT1292588B1 (it) * 1997-05-28 1999-02-08 Saitec Srl Procedimento per preparare forme alimentari ad elevata resa di sapore e le forme alimentari cosi' ottenute.
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
FR2806307B1 (fr) * 2000-03-20 2002-11-15 Mane Fils V Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation
SG98393A1 (en) 2000-05-19 2003-09-19 Inst Materials Research & Eng Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
US7201891B1 (en) * 2000-05-19 2007-04-10 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
CA2418490A1 (en) * 2000-08-11 2002-02-21 Eisai Co., Ltd. Drug-containing solid dispersion having improved solubility
BR0102252B1 (pt) * 2001-04-10 2013-10-22 Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
ITBO20020094A1 (it) 2002-02-22 2003-08-22 Tecnea Engineering S R L Procedimento per la realizzazione di composizioni ed apparecchiatura realizzante tale procedimento
JP2005298338A (ja) * 2002-02-27 2005-10-27 Eisai Co Ltd 速崩壊性圧縮成形製剤
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
WO2005049306A1 (en) * 2003-11-18 2005-06-02 Eurand Pharmaceuticals Limited Ultrasound-assisted compaction process with a compaction device made of coupled plastic-metal materials
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005024171A1 (de) * 2005-03-22 2006-09-28 Grünenthal GmbH Verfahren und Vorrichtung zur Ultraschallverpressung einer Tablette oder einer multipartikulären Arzneiform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
EP2131816A1 (en) * 2007-03-08 2009-12-16 Smithkline Beecham Corporation Pharmaceutical analysis apparatus and method
RU2351352C2 (ru) * 2007-04-09 2009-04-10 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Твердая нанокомпозиция для доставки биологически активных веществ
WO2009092601A1 (en) 2008-01-25 2009-07-30 Grünenthal GmbH Pharmaceutical dosage form
CN102123701B (zh) 2008-05-09 2013-03-27 格吕伦塔尔有限公司 使用喷雾冻凝步骤制备中间粉末制剂以及最终固体剂型的方法
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因(diacerein)之醫藥組合物
PE20121067A1 (es) 2009-07-22 2012-09-05 Gruenenthal Chemie Forma de dosificacion de liberacion controlada extruida por fusion en caliente
PL2456424T3 (pl) 2009-07-22 2013-12-31 Gruenenthal Gmbh Stabilizowana przed utlenianiem odporna na naruszenie postać dawkowania
NZ608865A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising an anionic polymer
BR112013005194A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo sal inorgânico
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
DK2736497T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
TR201815502T4 (tr) 2012-04-18 2018-11-21 Gruenenthal Gmbh Kurcalama veya dirençli ve doz boşalımına dirençli farmasötik dozaj formu.
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
WO2014191397A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
WO2015004245A1 (en) 2013-07-12 2015-01-15 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105555847B (zh) 2013-09-19 2018-08-10 微仙美国有限公司 聚合物膜
US9546236B2 (en) 2013-09-19 2017-01-17 Terumo Corporation Polymer particles
CN105916495B (zh) 2013-11-08 2019-11-12 泰尔茂株式会社 聚合物颗粒
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
CA2947786A1 (en) 2014-05-12 2015-11-19 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising tapentadol
CA2949422A1 (en) 2014-05-26 2015-12-03 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
CN107889459A (zh) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
CA3038719C (en) 2016-09-28 2020-04-21 Terumo Corporation Polymer particles

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2828206A (en) * 1954-02-24 1958-03-25 Roseuberg Adolf Stabilized fat-soluble vitamins and methods of making same
US3078216A (en) * 1961-04-11 1963-02-19 American Cyanamid Co Prolonged release oral pharmaceutical preparations
US3137630A (en) * 1961-06-09 1964-06-16 Eastman Kodak Co Process for preparing a dry, finely divided, gelatin particle product
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
ES297425A1 (es) * 1963-03-04 1964-06-01 Merck & Company Incorporated Procedimiento para preparar composiciones farmaceúticas en forma de tabletas de acción diferida
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS58172311A (ja) * 1982-04-02 1983-10-11 Kodama Kk 持続性製剤及びその製法
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
JPS6094403A (ja) * 1983-10-27 1985-05-27 Nippon Sangaria Bebaretsuji Co:Kk 超音波を利用した粉末製剤の製造方法
US4779806A (en) * 1984-07-23 1988-10-25 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
US4657543A (en) * 1984-07-23 1987-04-14 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
JPS649932A (en) * 1987-07-01 1989-01-13 Toyo Capsel Kk Soft capsule preparation using newly combined component as the base
ES2073507T3 (es) * 1989-04-12 1995-08-16 Procter & Gamble Composiciones de productos solidos de consumo que contienen complejos con ciclodextrina en forma de pequeñas particulas.
JP2958103B2 (ja) * 1989-12-12 1999-10-06 エーザイ株式会社 プラズマ照射固形製剤
JPH03287544A (ja) * 1990-04-05 1991-12-18 Biomaterial Universe Kk 生体分解吸収性高分子材料を用いた徐放性薬剤
FR2664851B1 (fr) * 1990-07-20 1992-10-16 Oreal Procede de compactage d'un melange pulverulent permettant d'obtenir un produit compact absorbant ou partiellement delitable et produit obtenu par ce procede.
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
RU2128499C1 (ru) 1999-04-10
JPH08504807A (ja) 1996-05-28
GR3031936T3 (en) 2000-03-31
CA2151396C (en) 2006-08-22
AU6043494A (en) 1994-07-19
ATE183641T1 (de) 1999-09-15
WO1994014421A2 (en) 1994-07-07
US5662935A (en) 1997-09-02
AU683044B2 (en) 1997-10-30
DK0675710T3 (da) 2000-03-27
EP0675710B1 (en) 1999-08-25
DE69326163T2 (de) 2000-05-04
KR960700043A (ko) 1996-01-19
EP0675710A1 (en) 1995-10-11
KR100297541B1 (ko) 2001-11-26
WO1994014421A3 (en) 1994-08-18
BR9307736A (pt) 1999-08-31
CA2151396A1 (en) 1994-07-07
JP3459421B2 (ja) 2003-10-20
DE69326163D1 (de) 1999-09-30

Similar Documents

Publication Publication Date Title
ES2138070T3 (es) Proceso para la preparacion de formas farmaceuticas de liberacion controlada y las formas obtenidas de esta manera.
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
HUT53873A (en) Insecticides comprising nitro compounds as active ingredient and process for producing the active ingredients
DE69318415D1 (de) Arzneitablette, die befähigt ist, einen oder mehrere wirkstoffe mit unterschiedlichen abgaberaten freizusetzen
ES2134501T5 (es) Composicion farmaceutica conteniendo un soporte fundible y procedimiento para su fabricacion.
ATE303140T1 (de) Tramadolhaltiges arzneimittel mit gesteuerter wirkstoffabgabe
HUT50794A (en) Herbicides comprising substituted benztriazole derivatives as active ingredient and process for producing the active ingredients
NO841518L (no) Delbare tabletter med forsinket frigjoering av virkestoff, og fremgangsmaate for fremstilling derav
PT672041E (pt) Derivados da piridina farmacologicamente activos e processos para a sua preparacao
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
PT94898A (pt) Processo para a preparacao de pastilhas medicamentosas de mascar rotogranuladas e cobertas por revestimento para mascarar o sabor
HUT53888A (en) Fungicides comprising pyrimidine derivatives as active ingredient and process for producing the active ingredients
MX9500159A (es) Preparacion farmaceutica percutanea.
CA2152795A1 (en) Readily available konjac glucomannan sustained release excipient
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
AR005353A1 (es) Formulacion de hormona para crecimiento animal de liberacion sostenida, y un procedimiento para la preparacion de la misma
NO965244D0 (no) Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav
HUT59319A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing same
DK0737069T3 (da) Deuterede aktive stoffer til transdermal administrering
NO961906L (no) Fremgangsmåte ved fremstilling av et klodronatpreparat
HUT53891A (en) Nematocide insecticide and acaricide comprising 5-substituted-3-arylisoxazole derivatives as active ingredient and process for producing the active ingredients
HUT46881A (en) Herbicides comprising cyclohexane-1,3,5-triones as active ingredient and process for producing the active ingredients
DK0758884T3 (da) Fremgangsmåde til fremstilling af indretninger til styret frigivelse af aktive stoffer
IT1263445B (it) Procedimento per preparare forme farmaceutiche a rilascio controllato/ritardato del principio attivo e le forme farmaceutiche cosi' ottenute
ES2146683T3 (es) Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19970406

FG2A Definitive protection

Ref document number: 675710

Country of ref document: ES